Clinical Trial Update: Phase I/II Trial of the Combination of Lenalidomide (Revlimid) and Nab-paclitaxel (Abraxane) in the Treatment of Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II trial evaluating lenalidomide with nab-paclitaxel in relapsed/refractory multiple myeloma; the study status is terminated with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Lenalidomide (lenalidomide)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: NYU Langone Health | Conditions: Relapsed or Refractory Multiple Myeloma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-09-05